Northern California Spinal Cord Patient Advocate appointed to State Stem Cell Agency Board
Richard Lajara, new member of CIRM governing board, in CIRM offices 2018 — photo provided by Lajara
The newest member of the governing board of California’s $12 billion stem cell agency is Richard Lajara, who also happens to be the first Californian to be enrolled in the nation’s first clinical trial involving a human embryonic stem cell therapy.
Lajara,…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.